Secure LoginLegal Cases
Cases in which Charles Yarborough, MD, MPH, has testified as an expert witness can be provided upon request.
Invited Presentations
Presentations and in-person appearances can be arranged for upcoming events and sessions. Below are past examples given by Dr. Yarborough to simply illustrate the range of some possible topics.
• Changing Landscape of Healthcare – Options for the Self Insured. Session 6.5 – Factors Influencing Employee’s Health: Access, Insurance and Human Resources. 1st International Symposium to Advance Total Worker Health, Bethesda, MD, Oct. 7, 2014.(Slides available here)
• Population health improvement as intentional business strategy. The Institute of Medicine’s Roundtable on Population Health Improvement, New York City, July 30, 2014.(In Chapter 5, which is available here)
Lockheed Martin has dozens of company sites across the country, and Yarborough described the method used to select the sites for the various outreach efforts as well as a report card to assess achievement levels for modifiable determinants of health.
The Site Selection Process
In selecting company sites for the launch of initiatives, the first key criterion is being ready. Yarborough referred to this as “persuadability,” or the potential for engaging in healthy actions. Persuadeability scores for each site take into account eight health actions: pedometer use, disease management, flu shot participation, biometrics, preventive examinations, cardiovascular exercise, nutrition, and stress management. Scores are determined using decision trees and regression analyses of de-identified data.5 The second key site criterion is the potential health benefit relative to the average prospective health care cost for each site’s employees. This is a proprietary risk score that comes from the company’s data warehouse vendor, Yarborough said. The score is based on a relative risk model and takes into account age, gender, and medical claims data as well as an analysis of known chronic conditions and acute and new conditions that might occur. Average scores are then plotted on a graph to identify the priority sites for intervention; these are sites that fall into the upper right quadrant in a diagram that maps both persuadability and potential benefits
Site Report Cards
As part of the Lockheed Martin HealthWorks employee health plan, employees and their spouses complete a voluntary and confidential well-being assessment. This health risk appraisal is used to create a personal roadmap to health for the individual. Using de-identified data from these assessment, Yarborough explained, scores were derived for individual behavior, physical environment, social and economic determinants, and health care in order to identify the areas where the company sites should focus attention. Scores were reported as grades (A through F), with the distribution of grades used as an indicator of performance.
• A Brave New World: Health Care Reform Opportunities and Practice Strategies of OEM Practice Setting. American Occupational Health Conference (Session 315), San Diego, March 12, 2013.
• Healthy Life Expectancy. The George Washington University School of Public Health. Washington, DC, April 18, 2014.
• Healthy Life Expectancy. TEDx Conference, Arcadia, CA, Nov. 23, 2013.
• Healthy Workforce Now: A Look at ACOEM’s National Advocacy Initiatives Promoting OEM. American Occupational Health Conference, May 1, 2013.
• Measurement Strategies for the 21st Century. The Conference Board’s 13th Annual Employee Health Conference, San Diego, March 12, 2013.
• Engaging Employers to Promote Value, Wellness, and Medical Homes, The Fifth National Medical Home Summit, Philadelphia, PA, March 15, 2013.
• Applying Private Sector Solutions to Achieve Total Population Health Management, Plenary Session of the 26th National Conference on Health, Productivity and Human Capital, Washington, DC, October 18, 2012.
• Optimizing health care delivery by integrating workplaces, homes, and communities. Mercer ORC Corporate Health Directors meeting, Washington, DC, August 7, 2012.
• Developing the Business Case for a Patient Centered Medical Home: The Power of Financial and Clinical Data (with RZ Goetzel). Thomson Reuters 2012 Healthcare Advantage Conference, Orlando FL, May 8, 2012.
• Worksite Clinics: Innovative Employer Strategies and Impact of Healthcare Reform (Session 305). American Occupational Health Conference. Los Angeles CA. May 1, 2012.
• Aligning the On-Site Health Clinic as Part of an Integrated Workforce Health System to Drive Employee Consumerism and Engagement. The World Congress 5th Annual Executive Forum On-Site Employee Health Clinics, Orlando, FL, Feb. 22, 2012.
• Capitalize on Patient-Centric, Coordinated Care through On-Site Clinic Models that Advance Clinical and Financial Outcomes. The Annual Employer Health & Human Capital Congress, Washington, DC, Feb. 9, 2012.
• Assessing Clinical Guideline Compliance. Thomson Reuters 2011 Healthcare Advantage Conference (with A Creighton), Salt Lake City, UT, May 11, 2011.
• Comparative Effectiveness Research: Corporate Medicine Perspective. American Occupational Health Conference. Washington, DC, March 29, 2011
• Corporate Medicine Overview. The Uniformed Services University of the Health Sciences, Bethesda, MD, Feb. 16, 2011.
• Lockheed Martin HealthWorks. Johns Hopkins School of Public Health. Baltimore, MD, Dec. 8, 2010.
• Shaping Convergent Trends for Comparative Effectiveness Research. CER: Informing Public and Private Payer Decision-Making. Co-sponsored by the National Pharmaceutical Council, The Health Industry Forum, America’s Health Insurance Plans, and the Blue Cross Blue Shield Association. Washington, DC, June 24, 2010.
• Worksite Clinics: Maximizing Synergy with Health Benefits and Care Management. Session Four: Business Health Agenda, Washington, DC, March 12, 2008.
• Comparative Effectiveness of Health Interventions: Business and Private Insurers. ERCI 15th Annual Conference. Washington, DC, Oct. 18, 2007.
• What Constitutes Excellence in Corporate Health Care. CDC/NIOSH WorkLife2007. Bethesda, MD, Sept. 10, 2007.
• Core curriculum: Reproductive health. State of the Art Conference, ACOEM, New York, NY, Oct. 18, 2006.
• Nanotoxicity: what is it and what should we do? (Invited plenary presenter). North American Congress of Clinical Toxicology Annual Meeting, San Francisco, CA, Oct. 6, 2006.
•Nanotechnology & Business Forum. Health risk assessments and commercial outlook of nanomaterials. Boston, MA, Jan. 19, 2006.
• Corporate Health Achievement Award. Executive Issues Business Forum, ORC Worldwide, Chicago, IL, Oct. 13, 2005.
•Nanotechnology and fibers. Second International Symposium on Nanotechnology (with F Mowat), Minneapolis, MN, Oct. 5, 2005.
• Chrysotile, nanoparticles, and risk of mesothelioma. Risk Assessment and Management session, American Industrial Hygiene Conference and Expo, Anaheim, California, May 25, 2005.
• Examiners Training Session for the Corporate Health Achievement Award, Annual meetings of the American Occupational Health Conference, 1996 – 2005.
• Corporate Health Achievement Award’s Self-Assessment Method (with K Peterson). American Occupational Health Conference, Washington, DC, 2005.
• What constitutes excellence for the Corporate Health Achievement Award. Scientific Session at the annual meetings of the American Occupational Health Conference, 1996–2005.
• Urinary alkyl phosphates for biomonitoring. International conference on pesticides and health, sponsored by the Society of Occupational and Environmental Health, National Institutes of Health, Bethesda, MD, July 8, 2002.
• Workplace surveillance of award winners. Workshop on Best Practices in Workplace Medical Surveillance, sponsored by the National Institute for Occupational Safety and Health (NIOSH) & National Occupational Research Agency (NORA), Cincinnati, OH, November 8, 2001. http://www.cdc.gov/niosh/sbw/posters/pdfs/yarborough.pdf.
• Lung cancer research issues related to diesel emissions. Diesel Research Workshop, Health Effects Institute, Stone Mountain, GA, April 21, 1999.
• Measuring value and client satisfaction in occupational health and safety. The Leadership Seminar: Measuring the Performance and Productivity Outcomes from Corporate Health Programs, Jefferson Medical College, Philadelphia, PA, October 1997.
• Quality assurance in occupational health: The market perspective. International Congress on Occupational Health, Stockholm, Sweden, September 17, 1996.
• Quality improvement in medical and disability management. State-of-the-Art Conference, ACOEM, Toronto, Canada, October 31, 1996.
• Corporate Health Achievement Award examiners training: scoring methodology. ACOEM Corporate Health Achievement Award. American Occupational Health Conferences, 1996–2003.
• Tuberculosis control for multi-national companies. American Occupational Health Conference, Las Vegas, Nevada, 1995.
• Strategic quality planning: from design to implementation. State-of-the-Art Meeting, ACOEM, New York, NY, October 1992.
• Baldrige award guidelines for occupational health management. American Occupational Health Conference, Washington, DC, April 1992.
• Significance of excess colorectal polyps and cancers. European Chemical Industry Ecology and Toxicology Center (ECETOC), Brussels, Belgium, October 10, 1990.
• Studies of workers in polyolefin manufacturing. American Occupational Health Conference, Houston, Texas, May 1990.